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Purpose: G Protein-Coupled Receptors (GPCRs) are a large family of therapeutically important proteins and as diverse
X-ray structures become available it is increasingly possible to leverage structural information for rational drug design.
We present herein approaches that use explicit water networks combined with energetic surveys of the binding site
(GRID), providing an enhanced druggability and ligand design approach, with structural understanding of ligand
binding, including a ‘magic’ methyl and binding site mutations, and a fast new approach to generate and score waters.
Methods: The GRID program was used to identify lipophilic and hydrogen bonding hotspots. Explicit full water
networks were generated and scored for (pseudo)apo structures and ligand-protein complexes using a new approach,
WaterFLAP (Molecular Discovery), together with WaterMap (Schrödinger) for (pseudo)apo structures. A scoring
function (MetaScore) was developed using a fast computational protocol based on several short adiabatic
biased MD simulations followed by multiple short well-tempered metadynamics runs.
Results: Analysis of diverse ligands binding to the adenosine A2A receptor together with new structures for the
δ/κ/μ opioid and CCR5 receptors confirmed the key role of lipophilic hotspots in driving ligand binding and
thus design; the displacement of ‘unhappy’ waters generally found in these regions provides a key binding
energy component. Complete explicit water networks could be robustly generated for protein-ligand complexes
using a WaterFLAP based approach. They provide a structural understanding of structure-activity relationships
such as a ‘magic methyl’ effect and with the metadynamics approach a useful estimation of the binding energy
changes resulting from active site mutations.
Conclusions: The promise of full structure-based drug design (SBDD) for GPCRs is now possible using a combination
of advanced experimental and computational data. The conformational thermostabilisation of StaR® proteins provide
the ability to easily generate biophysical screening data (binding including fragments, kinetics) and to get crystal
structures with both potent and weak ligands. Explicit water networks for apo and ligand-complex structures are
a critical ‘third dimension’ for SBDD and are key for understanding ligand binding energies and kinetics. GRID
lipophilic hotspots are found to be key drivers for binding. In this context ‘high end’ GPCR ligand design is now
enabled.
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GPCRs are one of the largest families of related proteins in
the human genome and as key regulators in the patho-
physiology of diverse diseases are generally considered ex-
cellent targets for drug discovery (Congreve et al., 2011).
X-ray structures of a diverse set of Family A GPCRs are
now known, with 20 published, in mainly inactive (antag-
onist/inverse agonist bound) but also active (agonist
bound) states, together with two recent family B structures,
and one family F structure (http://gpcr.scripps.edu/). The
use of fusion proteins, monoclonal antibodies and con-
formational thermostabilisation using the StaR® approach
has enabled this enormous recent progress (Bertheleme
et al., 2013; Wang et al., 2013; Hollenstein et al., 2013; Siu
et al. 2013) with the latter having the advantage that a very
potent ligand is not needed as part of the stabilisation.
These advances in structural biology have given ‘game-
changing’ insight into the binding sites of this superfamily
of receptors, facilitating full structure-based drug design
and providing templates for the construction of homology
models (Kobilka, 2013; Mason et al., 2012). The StaR
thermostabilisation process has enabled structures
with multiple ligands to be obtained at Heptares for
Drug Discovery projects including adenosine A2A re-
ceptor (A2A) antagonists, muscarinic M1 agonists and
dual orexin 1/2 antagonists.
In previous papers (Congreve et al., 2012; Mason et al.,
2012; Langmead et al., 2012) we discussed target drugg-
ability and the SBDD of novel ligands for the adenosine
receptor. Key aspects of these analyses were the water net-
work energetics and the properties of the binding site
determined by GRID (Goodford, 1985; Sciabola et al.,
2010) probes, in particular the hotspots for lipophilic
and hydrogen bonding groups. Regions with waters
termed ‘unhappy’ (as they would prefer to be in bulk
solvent, calculated using the WaterMap software) and
lipophilic/hydrophobic hotspots, particularly when ad-
jacent to hydrogen bonding hotspots, were found to be
drivers for druggability, allowing the efficient design of
potent ligands with good drug-like properties.
Waters are increasingly being implicated in many as-
pects of ligand binding (Snyder et al., 2011; Breiten
et al., 2013), including kinetics (Bortolato et al., 2013;
Pearlstein et al., 2013). Indeed, they can be considered to
be the third dimension in understanding ligand binding
and kinetics after the protein and the ligand. Water me-
diated interactions of ligands with receptors have always
been considered important, but generally ignored when
not seen directly in an X-ray structure. In GPCR-ligand
binding such interactions can be critical; ideally, compu-
tational approaches would be able to create and score
water networks in real-time for ligand design and bind-
ing mode analysis. We report herein results with a new
fast approach based on molecular interaction fields(MIFs) that have been over many years optimised in the
GRID and now FLAP/WaterFLAP software (Baroni
et al., 2007; FLAP/WaterFLAP 2013).
In this report, we continue to investigate the import-
ance of lipophilic hotspots in druggability using several
new peptide- and protein-binding GPCR X-ray struc-
tures, as well as multiple diverse ligands in a single
GPCR binding site. We previously highlighted how within
these lipophilic regions are often found ‘unhappy’ waters
(Mason et al., 2012), i.e. waters that energetically would
significantly prefer to be in bulk solvent (but remain as
creating a vacuum would be even less favourable). Potent
GPCR ligands have been seen in X-ray structures to dis-
place many such waters, and a druggability analysis looks
for these waters occurring in pockets that have hotspots
for both lipophilic and hydrogen-bonding (water probe)
groups, enabling ligands with drug-like properties to be
designed. We have further investigated the importance of
these lipophilic hotspots to drive ligand design by analys-
ing different series of adenosine A2A antagonists that bind
to different combinations of lipophilic hotspots, including
to a region where the waters did not at first stand out as
particularly ‘unhappy’ (WaterMap calculation).
To have available a fast approach to generate an expli-
cit and complete water network, robust for both apo and
ligand complex structures, we have investigated an alter-
native way of creating and scoring a water network,
using the GRID water probe iteratively to fill a binding
site with waters (placed in hotspots). It is also very use-
ful for design to have a water network with explicit hy-
drogens to show a plausible H-bonding network. The
initial network from the water hotspots can be opti-
mized using short equilibrating molecular dynamics
(MD) simulations and the waters rescored using GRID
probes. To this end a new probe (CRY) was created
(Bortolato et al., 2013) to bring together lipophilic and
hydrophobic probes. CRY is based on GRID C1= (carbon
sp2 probe, lipophilic) and the DRY probe (hydrophobic in-
teractions, limited entropy term). This new probe gives
the best of both in a single probe, used for scoring waters
and for a broader analysis of a binding site. An important
part of this approach was that the scoring of water ener-
gies would take into account an explicit network of waters
as well as the ligand.
In a further investigation of the role of water networks
in ligand binding we examined an interesting structure-
activity relationship (SAR), the ‘magic methyl’. One re-
cently reported that gives more than 30 fold increase in
potency for a μ opioid ligand (Lunn et al., 2011) could
not be investigated as structural data was not available.
We thus investigated an interesting ‘magic methyl’ effect
of similar magnitude (33x) in our chromone series of
A2A antagonists, with BioPhysical Mapping™ (BPM) data
(Zhukov et al., 2011) highlighting its binding mode, to
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explicit water networks, e.g. in molecular dynamics.
The analysis of the water network in the active site
can be important also for the understanding of site di-
rected mutagenesis effects on ligand binding. In particu-
lar we evaluated the possibility to apply WaterFLAP to
interpret BPM data (Zhukov et al., 2011; Bortolato et al.,
2013). BPM is an experimental approach used to map
binding site interactions with a ligand of interest. In the
BPM approach additional single mutations are added to
the StaR at positions that could be involved in small
molecule interactions. We combined WaterFLAP with a
fast protocol based on enhanced-sampling molecular dy-
namics (MetaScore) to estimate the effect of two binding
site mutations on two small molecules antagonists. Meta-
score is based on 6 quick consecutive adiabatic bias (AB)
MD simulations (Marchi and Ballone, 1999) and a total of
102 short well-tempered metadynamics runs (Barducci
et al., 2008). ABMD was used to predict a possible ligand
binding path. This method biases the system towards a
given value of coordinates of the atoms in the system, in
this case corresponding to the ligand-bound conform-
ation. A harmonic bias acts only when the distance to the
target bound state is bigger than its minimum value previ-
ously reached during the simulation (Marchi and Ballone,
1999). Metadynamics is an enhanced sampling algorithm
within the framework of classical MD that enables effi-
cient exploration of the multidimensional free energy sur-
faces of biological systems by adding a non-Markovian
(history-dependent) bias to the interaction potential in the
space defined by one or few collective variables (CVs).
Well-tempered metadynamics is a variant of the original
metadynamics algorithm that enables assessment of simu-
lation convergence while keeping the computational effort
focused on physically relevant regions of the conform-
ational space (Barducci et al., 2008). MetaScore uses a
path CV based on the ABMD binding path trajectory. In
this particular case, MetaScore was able to estimate the
qualitative effect of the mutation on the ligand binding
dissociation constant (KD). This method provides a further
complementary approach with WaterFLAP which is used
to propose a possible role of the water network on the
small molecule binding affinity.
Methods
Binding site analysis
Analysis and visualization of the protein binding site
hotspots was completed using GRID (Goodford, 1985;
Sciabola et al., 2010) energetic surveys and the resultant
maps for probes of interest. The C3 (sp3 carbon) methyl
probe was used to generate the surface of the protein active
site, in terms of how close a carbon atom can be. Lipo-
philic hotspots were identified using the C1= aromatic/sp2
carbon probe or with the new probe termed CRY thatcombines the C1= probe with the DRY hydrophobic probe,
that has an empirical entropy term. The CRY probe thus
provides a more complete mapping of the lipophilic and
hydrophobic hotspots in the binding site, and regions for
aromatic π-π stacking as well as small lipophilic hotspots
are identified. The CRY probe is used as part of the scoring
of waters.
Water network generation and scoring
As molecular dynamics studies can now be run much
faster, they can be used to rapidly refine a network and
provide more advanced scoring. Two approaches were
used, based on the GRID/WaterFLAP and WaterMap
software.
WaterFLAP
WaterFLAP is a new approach to generate and score
water networks for both apo and ligand-complex struc-
tures (WaterFLAP software is being developed in collab-
oration with Molecular Discovery). It represents an
extension of the FLAP software, where GRID water
hotspots are used in an iterative fashion, each iteration
taking into account the waters already added, to create
a complete water network. This initial network is sub-
jected to a short molecular dynamics (MD) optimisa-
tion. In the final optimized water network the waters
are scored using the water and CRY probes energies in
a manner that takes into account the presence of both
the ligand and all the rest of the water network. This
approach provides a protocol for the water network
creation and scoring that is complementary to the
other method used, WaterMap (2013). WaterFLAP can
be applied to a protein-ligand complex in less than 2
hours on a desktop workstation including molecular
dynamics optimization.
Water network creation
Initial placement of water was calculated by the Flap-
water module in FLAP/WaterFLAP (2013) at a radius of
10 Å from the ligand. Water is placed in the most
favourable positions based on the water OH2 GRID hot-
spots iteratively, where GRID hotspots are recalculated
after each round of water placement. An energy cutoff is
used, where only waters under the cutoff are considered at
each iteration, and the cutoff is raised at each iteration
from an initial to final cutoff energy. Flapwater was run to
convergence, with an initial cutoff energy of -8 kcal/mol
and a final cutoff energy of -1 kcal/mol.
To achieve a hydrogen bonded water network, the initial
Flapwater output was relaxed with a short MD simulation.
Simulations were run using the GROMACS (v4.6.1) soft-
ware package. The protein and ligand complex was simu-
lated in a box containing the initial waters placed by
Flapwater, and solvated with an additional ~13,000 explicit
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tions were run in the NPT ensemble (constant number of
molecules, pressure, and temperature) at 300 K using the
AMBER99SB all-atom force field (Lindorff-Larsen et al.,
2010). Ligand parameters were calculated using the
ACPYPE software (Sousa da Silva and Vranken, 2012),
also based on the GAFF force field parameters. Simula-
tions were run for 20 ps, using a timestep of 0.002 ps,
with the protein and ligand heavy atoms under pos-
itional restraints, and the water atoms free to move.
The final frame of the 20 ps simulation was saved for
further analysis. Waters within a 8 Å radius of the lig-
and were rescored after a single iteration of refinement
using the water OH2 and CRY probe of the GRID
program.
Adenosine receptor with triazine ligands
Inactive adenosine A2A StaR receptor in complex with
triazine 4g (PDB:3UZA), and triazine 4e (PDB:3UZC),
was used as the starting structure. Ligands 4a and 4d
were superimposed on the 4g ligand in structure 3UZA
as the starting position. Flapwater followed by a 20 ps
MD simulation (described above) was run separately for
each starting structure. This method is fast, completing
in < 2 hours on a single Intel 3.6 GHz cpu, with Flap-
water and rescoring as the slowest steps.
WaterMap
WaterMap (Abel et al., 2011; Beuming et al., 2012; Wang
et al., 2011) is established software from Schrödinger that
exploits an all atom explicit solvent molecular dynamics
simulation followed by a statistical thermodynamic ana-
lysis of water clusters (hydration sites). Briefly, in Water-
Map a pre-production simulation of 120 ps at 300 K is
followed by a production simulation of 2 ns at 300 K in
the NTP ensemble. The excess entropy is computed by
numerically integrating a local expansion of spatial and
orientational correlation functions. The enthalpy is com-
puted by averaging the molecular mechanics energies of
the water molecules in each hydration site over all frames
of the molecule dynamics simulation. WaterMap waters
that are calculated to have a significant positive free en-
ergy relative to being in bulk solvent are termed ‘unhappy’
and are coloured red in the figures. WaterMap was only
used for (pseudo)apo structures in the work presented
here.
Ligand binding changes on changing structure
The adenosine A2A receptor chromone ligands showed
some cases of strong SAR, such as a ‘magic methyl’. To test
whether water placement followed by MD simulation
could differentiate strong versus weak binders, and provide
a structural understanding, we modelled starting positions
of ligands chromone12 and des-methylchromone12 intothe high-resolution adenosine A2A receptor structure
(PDB:4EIY). For the more potent ligand chromone12
the position from Biophysical Mapping (Langmead
et al., 2012) supported by a lower resolution X-ray
structures (unpublished data) was used, with the me-
thyl on the thiazole removed for the initial placement
of the des-methyl derivative. In the starting position
both ligands make a crucial hydrogen bonding inter-
action with key residue Asn2536.55. After initial water
placement with WaterFLAP, MD simulation was run
for 100 ps with positional restraints on the protein
heavy atoms, but no positional restraints on the ligand
or water positions. The MD simulation took <1 hour
on 16 AMD 6386 SE CPU cores, making this a poten-
tially relatively fast and inexpensive method to predict
relative binding affinities of small changes in ligand
structure.
MetaScore
The 3D coordinates of the adenosine A2A receptor in
complex with 4g (PDB:3UZA) (Congreve et al., 2012)
and ZM241385 (PDB:3PWH) (Dore et al., 2011) were
used. The receptors have been prepared with the Protein
Preparation Wizard in Maestro 9.2 (2011), hydrogen
atoms were added and the H-bond network optimized
through an exhaustive sampling of hydroxyl and thiol moi-
eties, tautomeric and ionic state of His and 180° rotations
of the terminal dihedral angle of amide groups of Asp and
Gln. The tautomer with the hydrogen on the δ nitrogen
has been considered for His2787.43 (superscripts refer to
Ballesteros-Weinstein numbering) (Ballesteros et al., 1995).
Hydrogen atoms have been energy minimized using the
OPLS2005 force field. The A2A StaR system used to deter-
mine the SPR measurements from which the kinetics were
derived (Congreve et al., 2012; Zhukov et al., 2011) have
been created for both complexes in silico, back mutating
A2777.42 to the wild type residue Ser using Maestro and
optimizing the side chain conformation. In a similar way
the mutant L85A1.52 has been created.
We developed a scoring function (MetaScore) using a
fast computational protocol based on several short adia-
batic biased molecular dynamics simulations (Marchi
and Ballone, 1999; Provasi and Filizola, 2010) followed
by multiple short well-tempered metadynamics runs
(Barducci et al., 2008; Provasi et al., 2009). Metascore is
based on an automatic python script protocol using
the molecular dynamics software GROMACS (v4.6.1),
PLUMED (v1.3.0) and the PyMol API. MetaScore is
composed of two stages, each divided in two steps.
Stage 1 - binding path prediction. This is calculated
once per protein-ligand complex (4 g-A2A StaR and
ZM241385-A2A StaR).
(Step A) System creation and quick MD simulation.
The ligands were manually positioned in Maestro in the
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final docked position. The AMBER99SB force field (Lin-
dorff-Larsen et al., 2010) parameters were used for the
protein and the GAFF force field (Wang et al., 2004) for
the ligands using AM1-BCC partial charges (Jakalian
et al., 2002). A triclinic box was defined with at least 20
Å of solvation layer around the system with periodic
boundary conditions. The SPC water model was used
and ions were added to neutralize the system (final con-
centration 0.01 M). Position restraints were always ap-
plied to protein Cα atoms (1000 kJ-1 mol-1 nm-1).
Lennard-Jones and Coulomb interactions were treated
with a cutoff of 1.1 nm with particle-mesh Ewald electro-
statics (PME) (Darden et al., 1993). An energy
minimization protocol based on 200 steps steepest-descent
algorithm followed by 1000 steps conjugate gradient algo-
rithm is applied to the system. A quick 2 ps MD is exe-
cuted in the NPT ensemble using v-rescale (Bussi et al.,
2007) (tau_t = 0.1 ps) for the temperature coupling to
maintain the temperature of 300 K and using Berendsen
(Berendsen et al., 1984) (tau_p = 0.5 ps) for the pressure
coupling to maintain the pressure of 1 bar.
(Step B) Adiabatic bias MD. 6 consecutive simulations
of 50 ps each were used to simulate the binding event of
the ligand to the protein. The ligand target conformation
(using in PLUMED the MSD TARGETED option) was
the final crystallographic pose of the small molecule in
the receptor. For the first simulation the initial target
and kappa values were 10 Å and 1 kJ/nm2. After each
simulation the target value was divided by 100 and the
kappa multiplied by 100. For this part, the Parinello-
Rhaman barostat (Parinello and Rhaman, 1981) barostat
was used instead of Berendsen. 102 snapshots are at the
end generated from the binding path trajectory.a b
Figure 1 Druggability analysis for the δ, μ and κ opioid GPCR structu
(PDB:4EJ4). (b) Inactive conformation of μ opioid with β-funaltrexamine bo
bound (PDB:4DJH). The carbon atoms of the ligands are coloured cyan. GR
manner: C1= probe (lipophilic) in yellow at –2.7 kcal/mol, water (OH2) probe
which defines the pocket surface in terms of how close a ligand carbon atom
colour coded in red if predicted to have a free energy (ΔG) >3.5 kcal/mol, in
–1.0 to 2.0 kcal/mol and in blue if ΔG< –1.0 kcal/mol. All WaterMap free energy
(OpenEye) using the same ligand-protein orientation shown in Congreve et al.Stage 2 - Metadynamics energy evaluation of the bind-
ing path. The same binding path is used for the A2A
StaR, L85A and S277A mutants. For every snapshot of
the 102 generated by Stage 1 the following steps are
executed:
(Step A) System creation and quick MD simulation.
The protein and ligand are structurally aligned to the
corresponding protein and ligand in the snapshot. The
same protocol of Stage 1 - Step A is executed.
(Step B) Metadynamics. We used a 2 ps well-tempered
metadynamics (simulated temperature 300 K, bias factor
50, initial energy bias Gaussian height of 3 kcal/mol)
using 1 path collective variable (S_PATH, Lambda = 0.6
and Sigma = 0.1) based on two reference frames: the
starting unbound ligand conformation and the final
protein-bound crystal pose. The Parinello-Rhaman baro-
stat was used instead of Berendsen.
In Stage 2, all the 102 independent metadynamics runs
explore the same energy surface corresponding to the
binding event (they are writing to the same HILLS file
and the PLUMED keyword RESTART is used). The final
MetaScore ΔGbind for the ligand is calculated as the en-
ergy difference between the bound state and the un-
bound state (Figure 1).
Results and discussion
Druggability update for GPCRs
We have extended our previous druggability analysis
(Mason et al., 2012) to newer GPCRs, namely the opioid
and chemokine receptor structures. In addition, the ana-
lysis of two lead discovery projects for the adenosine
A2A receptor highlights how lipophilic hotspots are key
drivers for ligand binding and design. It is now clear that
potent compounds can be designed that interact withc
res. (a) Inactive conformation of δ opioid with naltrindole bound
und (PDB:4DKL). (c) Inactive conformation of κ opioid with JDTic ligand
ID maps are contoured (transparent solid) and coloured in the following
in green at –6.0 kcal/mol, CH3 methyl group probe in grey at 1 kcal/mol
can go. WaterMap water clusters (shown as large spheres) have been
yellow if their predicted ΔG is between 2.0 and 3.5 kcal/mol, in grey if ΔG is
estimations are relative to bulk solvent. All figures have been made in VIDA
(2011) and Mason et al. (2012).
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The GRID C1= (carbon sp2) probe is particularly effect-
ive in the detection of lipophilic regions that are often
occupied by ‘unhappy’ waters (Mason et al., 2012). These
are waters that energetically would significantly prefer to
be in bulk solvent but remain as creating a vacuum
would be even less favourable. X-ray structures show
displacement of such waters, that drives GPCR ligand
potency. A druggability analysis looks for ‘unhappy’ wa-
ters occurring in pockets that have hotspots for both
lipophilic and hydrogen-bonding (water probe) groups,
enabling potent ligands with drug-like properties to be
designed.
Several important new GPCR structures have been
published since our druggability paper, including three
opioid structures in the inactive form. Figure 1a-c shows
the druggability analysis for the δ, μ and κ opioid GPCR
structures with ligands bound. The ligands all bind deep
in the pocket, with two key lipophilic hotspot interac-
tions that contain ‘unhappy’ waters. The most recent
structure is the C-C chemokine receptor type 5 (CCR5)
structure (Tan et al., 2013) in complex with maraviroc
(Selzentrty)(PDB:4MBS), that highlights the exciting new
insights for drug design usually found with new GPCR
structures. This structure reveals a chemokine binding
site quite different from the previous chemokine struc-
ture, the CXCR4 structure (Wu et al., 2010). The ligand
binds in an extended conformation deeper in the site, at a
similar depth to many other Family A GPCRs (Figure 2a).
Trp86 on helix 2 has moved to create a larger pocket deep
in the site. Interestingly there are now 3 lipophilic hot-
spots, spread over 14 Angstroms, all covered by mara-
viroc; in the CXCR4-IT1t structure there was a single
large lipophilic-only hotspot with the ‘unhappy’ waters
higher in the site (Figure 2b and aligned with the CCR5a b
Figure 2 Druggability analysis for the CCR5 chemokine GPCR structur
inactive conformation of the chemokine CCR5 with maraviroc (carbon atom
with IT1t (carbon atoms in cyan) (PDB:3ODU). (c) For comparison, the posit
the binding site of the CCR5 structure with maraviroc bound. The GRID ma
in Figure 1.structure in Figure 2c). The centre lipophilic hotspot
(phenyl group in maraviroc) is lipophilic only, as is the less
deep single hotspot in the CXCR4-IT1t structure, but the
other two lipophilic hotspots are more druggable, with ad-
jacent water hotspots. This is shown in Figure 2a (GRID
lipophilic and water hotspots in yellow and green respect-
ively). These three key lipophilic hotspots contain ‘un-
happy’ waters (shown for the WaterMap calculation on
pseudo-apo structure) and provide a framework to drive
the design of new ligands. Figure 3a shows the result for
the same structure using the new WaterFLAP protocol
resulting in a similar prediction, with the lipophilic hot-
spots containing the most ‘unhappy’ waters. In Water-
FLAP waters are iteratively added to GRID water probe
hotspots, the resulting network is optimised using MD
and the final waters are rescored with GRID water and
CRY probes. The WaterFLAP protocol we use, initial
water placement followed by a short MD optimization of
the network, is also good at producing explicit water net-
works for ligand-protein complexes, to aid further design
etc., and the results for the maraviroc complex are shown
in Figure 3b.
Importance of lipophilic hotspots for ligand binding
The availability of multiple diverse X-ray structures for
the adenosine A2A receptor in complex with antagonist
or experimentally-enabled docking poses enables a broader
view of the ligand-efficient binding modes. Figure 4a shows
two potent leads from the triazine and chromone series
bound, together with the GRID lipophilic hotspots. It is
clear that between the two series all the lipophilic hotspots
are used, in different combinations. The WaterMap waters
for the pseudo-apo structure are shown in Figure 5a and
the WaterFLAP waters in Figure 5b. The water networks
were calculated for the pseudo-apo structure to highlightc
e with maraviroc bound using GRID and WaterMap. (a) The
s in green) bound (PDB:4MBS). (b) Inactive CXCR4-T4L in complex
ion of the ligand IT1t from the aligned CXCR4 structure is shown in
ps and WaterMap waters are contoured and colour coded as
a b
Figure 3 WaterFLAP water networks for the CCR5 chemokine GPCR structure with maraviroc bound. (a) The water network for the
pseudo-apo structure from WaterFLAP post MD and rescored with the GRID water and CRY probes, coloured from red to blue for ‘unhappy’ to
‘happy’. (b) The water network from WaterFLAP of the complex post MD; the Glu283 interacting with the maraviroc basic nitrogen is highlighted
in stick. The GRID C1= lipophilic hotspot map is shown in yellow contoured at -2.7 kcal/mol in each figure.
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pseudo-apo structure was used as this gave best results,
but as shown in Figure 4b-c-d WaterFLAP was also used
robustly for the A2A triazine complexes, showing clearly
the difference in networks for the different potency ligands.
The druggable subpocket with a lipophilic hotspot used byba
dc
Figure 4 Analysis of the binding of two potent ligand series found by
4e (cyan carbon atoms) bound to the inactive conformation of A2A (PDB:3
(pKi 8.5) from Biophysical Mapping™ and X-ray data (unpublished) show
with lipophilic hotspots in yellow at -2.5 kcal/mol, water hotspots in gre
MD in stick for the X-ray complex of compound 4e with the A2A recepto
with only the GRID lipophilic hotspots shown. (c) The WaterFLAP calcula
4g with the A2A receptor showing a good network with the pyridine; GRID wa
WaterFLAP for the less potent phenyl analog (N→ C) 4d.the propyl group of the chromone ligand was best distin-
guished by WaterFLAP, that predicted the region to be oc-
cupied by yellow and red ‘unhappy’ waters; WaterMap
predicted one ‘happy’ (between 1st and 2nd carbon of the
propyl group) and one ‘unhappy’ more distant water. This
region is less evident in the lower resolution ZM214385His278
virtual screening for the adenosine A2A receptor. (a) The triazine
UZC) together with a high confidence docking of the chromone12
ing how each ligand exploits two key lipophilic sites; GRID maps
en at -6 kcal/mol. (b) The WaterFLAP calculated water network post
r with the histidine H-bonding to the phenol highlighted in stick
ted water network post MD in stick for the X-ray complex of compound
ter probe only shown. (d) For comparison, the network calculated by
a b c
Figure 5 Water networks from WaterMap and WaterFLAP for the pseudo-apo adenosine A2A receptor shown with two potent ligands.
(a) The WaterMap waters for the high resolution A2A structure (PDB:4EIY) are colour coded as in Figure 1, with the ‘unhappy’ waters in red and
yellow. (b) The WaterFLAP waters with the ‘unhappy’ waters coded in red then yellow. (c) Waters calculated by both WaterMap and WaterFLAP
are shown, with WaterFLAP waters distinguished by a white circle. Also shown in a ‘glowing’ green are the crystallographic waters from the high
resolution structure with ZM241385 (PDB:4EIY), that binds similar to the chromone (but does not have the propyl chain, see figure 10 in
Congreve et al., 2011). The GRID lipophilic C1=map is contoured at -2.5 kcal/mol together with the water (OH2) probe in green at –6.0 kcal/mol
to highlight the druggability and key binding regions of the binding pocket; CH3 methyl group probe shown in grey at 1 kcal/mol to define the
pocket shape.
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greve et al., 2011), the triazine 4g (PDB:3UZA, one yellow
water, Figure 1e in Mason et al., 2012); and the 4e triazine
complex (PBD:3UZC, both grey, Figure 2 in Andrews SP,
Mason JS, Hurrell E, Congreve M: Structure-Based Drug
Design of Chromone Antagonists of the Adenosine A2A
Receptor. Med Chem Comm, accepted)(WaterMap calcu-
lations). The general consensus in both the position and
energy of waters in the site from the very different ap-
proaches WaterMap and WaterFLAP can be seen in
Figure 5c, where both are shown. Also included in Figure 5c
are the binding site crystallographic waters from the high
resolution ZM241385 structure, which encouragingly
were all mapped in a similar region by the computa-
tional methods, WaterFLAP finding all of them. Note
that a simple approach using an MD optimization of
the protein-ligand-water network using a default equil-
ibrated box of TIP3P waters (i.e. skipping the initial
water placement based on GRID) does not work,
resulting in a completely ‘dewetted’ binding site. It is
important to be able to predict the water network for
GPCR ligand complex structures as the high resolution
required to accurately identify crystallographic waters
is rarely achievable with GPCR structures; experience
with GPCR StaR structures at Heptares has shown
though that the ligand electron density however is well
defined even at lower overall resolutions. Irrespective
of the source of the waters, having a computational es-
timation of the relative free energies of the waters is a
very useful addition.The WaterFLAP approach used (GRID-based water
placement followed by MD optimization) is good at pro-
ducing complete water networks for these ligand com-
plexes with explicit optimised H-bonding networks, and
this is shown in Figure 4b, 4c and 4d for the X-ray com-
plexes of the triazines 4e, 4g and 4d. The role of the
pyridine nitrogen in producing a good network can be
seen, the positive effect of the pyridine N on binding not
being evident by looking at only ligand-receptor com-
plexes. The less optimal water network deep in the bind-
ing site is also shown for the phenyl analog in Figure 4d.
Water network energetics were shown (Bortolato et al.,
2013) for a series of triazine analogues for the A2A re-
ceptor to be related to residence times, with a change of
off-rate from 0 s to 87 s to 990 s for the unsubstituted
phenyl to dimethyl pyridine (4e) to chlorophenol (4g)
compounds. In particular ‘unhappy’ waters trapped be-
tween the ligand and the protein can be qualitatively
linked to the decrease of the small molecules residence
time.
Structural rationalization of a ‘magic methyl’ in A2A
chromone antagonist ligands
Chromone12 (Langmead et al., 2012) is known to bind
potently with a pKi of 8.5 to the A2A receptor, while the
des-methyl derivative binds with a significantly 33x
lower affinity (Andrews SP, Mason JS, Hurrell E, Con-
greve M: Structure-Based Drug Design of Chromone
Antagonists of the Adenosine A2A Receptor. Med Chem
Comm, accepted). This is a similar difference in activity
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2011) for a series of opioid antagonists but with no
structural rationalization.
To explain the significantly decreased affinity of the
des-methyl compound we used water network place-
ment and MD simulation to measure the effect of the
ligand methyl on the binding and water network (Figure 6).
The binding mode of chromone compound 12, consistent
with the Biophysical Mapping data (Langmead et al.,
2012) and X-ray structural data (unpublished data), has
the thiazole nitrogen hydrogen bonded to the key residue
Asn2536.55. This places the methyl group into a small
hydrophobic pocket bounded by Met177 and Leu249.
Both the WaterMap and WaterFLAP analyses place a very
‘unhappy’ water in the position occupied by the ligand
methyl. The significant affinity gain by having this sub-
stituent can thus be understood in terms of the favourable
lipophilic/hydrophobic interaction coupled to the free en-
ergy gain from displacement of the ‘unhappy’ water.
To structurally understand the effect on binding of re-
moving this methyl group, a water network was gener-
ated with WaterFLAP and a longer, unconstrained MD
run. Removing the methyl without adjusting the ligand
placement would leave a vacuum in the protein structure
that is not large enough for a water molecule and for
this reason we postulated that the des-methyl ligand
would bind higher in the binding site (i.e. closer to the
extracellular side) thereby weakening the hydrogen bond
to the critical Asn2536.55, and allowing at least one ‘un-
happy’ water back into the lipophilic pocket. Indeed,cba
Figure 6 WaterFLAP predictions for the A2A chromone ligands chrom
chromone 12 and the des-methyl analog. (c) The potent chromone12 ligan
group remaining anchored in the lipophilic pocket bounded by Met177 and
while the final position is shown in grey stick. The ligand retains a hydrogen b
lower half of the binding site are shown. (d) Removal of the methyl leaves a v
moves up during MD simulation, resulting in a weakened interaction with As
in the orange circle; see Figure 5 where there is an ‘unhappy’ water in this re
affinity.after a 100 ps MD simulation the des-methyl derivative
moves up, weakening the hydrogen bond, and water
molecules move back, able to hydrogen bond to the sur-
rounding water network (Figure 6f ). The water positions
are similar to those calculated for this region in the apo
structure (Figure 5) that were scored as ‘unhappy’; the
proximity of the ligand carbon atoms in the complex
trapping the waters would be expected to make these
waters even more ‘unhappy’. As a control, in the same
MD simulation on the potent chromone12 the ligand
moves very little after 100 ps, maintaining a hydrogen
bond with Asn2536.55 (Figure 6c). This postulated change
in position of the core binding group in the chromone
series when the methyl is removed is another example of
the danger of transferring SAR between compounds as-
suming a common binding position of the core group.
Structural interpretation of mutational data in GPCR
binding sites
Biophysical Mapping (BPM) is an experimental approach
used to map binding site interactions with a ligand of
interest (Zhukov et al., 2011). In the BPM approach add-
itional single mutations are added to the StaR at positions
that could be involved in small molecule interactions. The
StaR and the panel of binding site mutants are captured
onto Biacore chips to enable characterization of the bind-
ing of small molecule ligands using surface plasmon
resonance (SPR) measurement. A matrix of binding
data for a set of ligands versus each active site muta-
tion is then generated, providing specific affinity andd
one12 and the des-methyl analog. (a-b) 2D ligand structures of
d (pKi 8.5) is stable under 100 ps of MD simulation, with the methyl
Leu249. The starting position of the ligand is shown in cyan wireframe,
ond to the key residue Asn253, shown in stick, and MD waters in the
acuum in the structure, that is filled by a water molecule when the ligand
n253 and ‘unhappy’ water(s) now filling this lipophilic region (highlighted
gion in the pseudo-apo structure). This compound has 33x reduced
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ligand interactions. This data set, in combination with
molecular modeling and docking, is used to map the
small molecule binding site for every compound.
We developed a fast computational protocol to better
understand in silico the BPM results based on a combin-
ation of enhanced sampling MD (MetaScore) and water
network perturbation predictions (WaterFLAP). Meta-
Score uses adiabatically biased MD to evaluate a possible
ligand binding path from the bulk solvent to the final
crystallographic pose and metadynamics to evaluate the
energy profile of the binding event (Figure 7). Water-
FLAP allows the prediction of mutation effects on the
water network in close proximity to the small molecule,
and hence to the binding affinity.
We applied the two novel in silico approaches to the
adenosine A2A receptor in complex with two small mol-
ecule antagonist: ZM241385 and 4g. We evaluated the
effect of the mutations L85A1.52 and S277A7.42 on ligand
binding. The predictions were compared to the experi-
mental BPM results (Zhukov et al., 2011). For both li-
gands MetaScore was able to reproduce in silico the
qualitative affinity (pKD) change (increase or decrease)
resulting from the mutations (Figure 8) compared to the
original StaR receptor. We used WaterFLAP to better
understand the effect of perturbations in the receptor-
ligand-water network as a consequence of the mutations,
and to relate these to ligand affinity. Decrease of antag-
onist affinity seems related to additional ‘unhappy’ wa-
ters trapped between the ligand and the protein
(Figure 8c-d-g), while increase of affinity is linked to the
displacement of one ‘unhappy’ water (Figure 8h). While
MetaScore can qualitatively predict the pKD changeFigure 7 Example free energy surface predicted by MetaScore for liga
calculated as the energy difference between the bound state and the unbresulting from mutations, WaterFLAP can give insight
into the effect of the mutation even when the residue is
not in direct contact with the ligand, through water net-
work perturbation.
These preliminary results suggest that the combination
of MetaScore and WaterFLAP can be an interesting
computational protocol applicable to understand site di-
rected mutation (SDM) data and to rescore docking
poses. The approach is at the moment under testing and
active development aiming to achieve a method accurate
and fast enough to be usable in hit-to-lead or lead-
optimization phases of drug discovery.
Conclusions
Several recent advances in GPCR biophysical screening
and X-ray crystallography allow for advanced structure-
based drug design (SBDD), which we have termed ‘high
end design’. These include: (1) The availability of X-ray
structures of a diverse set of GPCRs in complex with
multiple ligands, (2) StaR proteins, which allow among
others fragment screening, Biophysical Mapping and
binding kinetics and (3) computational analyses and de-
sign approaches that consider explicit waters and their
calculated energies.
We consider the complete water network to be an es-
sential third dimension in ligand design (after the pro-
tein and ligand structure), and this has been illustrated
for several GPCR structures. This includes the estima-
tion of relative water free energies, for both (pseudo)apo
and ligand complex structures, that can be used for
druggability, ligand binding (including selectivity) and
binding kinetics estimations. It would be expected that











































a b c d
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Figure 8 WaterFLAP predictions for the ligands ZM241385 (top row) and 4g (bottom row). Ligand 2D molecular structures are shown on
the left (a and e). For every protein-ligand complex the affinity (pKD) and the MetaScore ΔGbind in kcal/mol is reported. The effect of the mutation
decreasing or increasing the affinity compared to StaR is highlighted respectively in red and green. In the 3D figures (b, c, d, f, g and h), ligands
are shown in light orange stick representation, while residues 85 and 277 are shown in grey stick. Predicted water molecules are shown as sphere
colour-coded by estimated free energy of interaction (using the GRID OH2 and CRY probes) from red (high energy, ‘unhappy’) to blue (low energy,
‘happy’). Only water molecules relevant to understand the BPM results are shown. Water molecule differences between the StaR and the protein
mutants are highlighted by a black circle. The shape of the ligand binding site is represented using a solid grey surface created using the
GRID C3 probe (carbon sp3) with a threshold energy value of 1 kcal/mol.
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previous paper (Mason et al., 2012). The ability to rapidly
see explicit hydrogen bonded water networks, and to esti-
mate free energy differences, for existing and proposed lig-
and modifications should not be underestimated. Linked to
these calculations are the GRID energetic surveys of the
site, that are found to be extremely useful in driving ligand
design and evaluating docking poses. In particular the
lipophilic hotspots from the C1= and the new CRY probe
appear to be important in all the GPCR structures we have
studied. The new software WaterFLAP, used in our proto-
col in conjunction with MD optimization, is showing great
promise in providing an additional way to generate and
score water networks for ligand-protein complexes,complementary to the established more computationally
intensive and rigorous MD based approach WaterMap.
High end GPCR design has arrived!
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